India to get third vaccine as Russia’s Sputnik V receives nod from experts
Sputnik V has been recommended for emergency use by Subject Expert’s Committee
Now the vaccine needs approval from DCGI for its emergency use in India
Currently, Serum Institute’s Covishield and Bharat Biotech’s Covaxin are used in India
Hyderabad’s Dr Reddy’s Laboratories partnered with RDIF for Sputnik V’s clinical trial in India
Dr Reddy’s Laboratories last week announced that Sputnik V has an efficiency rate of 91.6%
